Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

David Ross; Ilaria Pagani; Yazad Irani; Jade Clarson; Tamara Leclercq; Phuong Dang; Jennifer McLean; Verity Saunders; Lisa Carne; John Reynolds; David Ritchie; Deborah White; Susan Branford; Timothy Hughes; Agnes Yong

doi:10.1111/bjh.15894

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

David Ross
, Ilaria Pagani
, Yazad Irani
, Jade Clarson
, Tamara Leclercq
, Phuong Dang
, Jennifer McLean
, Verity Saunders
, Lisa Carne
, John Reynolds
, David Ritchie
, Deborah White
, Susan Branford
, Timothy Hughes
, Agnes Yong

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	e56-e60
Number of pages	4
Journal	British Journal of Haematology
Volume	186
Issue number	3
Early online date	2019
DOIs	https://doi.org/10.1111/bjh.15894
Publication status	Published - Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

chronic myeloid leukaemia
immunology
minimal residual disease
treatment-free remission

Access to Document

10.1111/bjh.15894

Cite this

Ross, D., Pagani, I., Irani, Y., Clarson, J., Leclercq, T., Dang, P., McLean, J., Saunders, V., Carne, L., Reynolds, J., Ritchie, D., White, D., Branford, S., Hughes, T., & Yong, A. (2019). Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia. British Journal of Haematology, 186(3), e56-e60. https://doi.org/10.1111/bjh.15894

@article{e177d68ac8fd489984e932ba585f118c,

title = "Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia",

keywords = "chronic myeloid leukaemia, immunology, minimal residual disease, treatment-free remission",

author = "David Ross and Ilaria Pagani and Yazad Irani and Jade Clarson and Tamara Leclercq and Phuong Dang and Jennifer McLean and Verity Saunders and Lisa Carne and John Reynolds and David Ritchie and Deborah White and Susan Branford and Timothy Hughes and Agnes Yong",

year = "2019",

month = aug,

doi = "10.1111/bjh.15894",

language = "English",

volume = "186",

pages = "e56--e60",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley \& Sons, Inc",

number = "3",

}

Ross, D, Pagani, I, Irani, Y, Clarson, J, Leclercq, T, Dang, P, McLean, J, Saunders, V, Carne, L, Reynolds, J, Ritchie, D, White, D, Branford, S, Hughes, T & Yong, A 2019, 'Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia', British Journal of Haematology, vol. 186, no. 3, pp. e56-e60. https://doi.org/10.1111/bjh.15894

TY - JOUR

T1 - Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

AU - Ross, David

AU - Pagani, Ilaria

AU - Irani, Yazad

AU - Clarson, Jade

AU - Leclercq, Tamara

AU - Dang, Phuong

AU - McLean, Jennifer

AU - Saunders, Verity

AU - Carne, Lisa

AU - Reynolds, John

AU - Ritchie, David

AU - White, Deborah

AU - Branford, Susan

AU - Hughes, Timothy

AU - Yong, Agnes

PY - 2019/8

Y1 - 2019/8

KW - chronic myeloid leukaemia

KW - immunology

KW - minimal residual disease

KW - treatment-free remission

UR - https://www.scopus.com/pages/publications/85063487180

U2 - 10.1111/bjh.15894

DO - 10.1111/bjh.15894

M3 - Letter

SN - 0007-1048

VL - 186

SP - e56-e60

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -

Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia

UN SDGs

Keywords

Access to Document

Other files and links

Cite this